Nathan and Oski's Hematology of Infancy and Childhood

Expert Consult: Online and Print

Nathan and Oski's Hematology of Infancy and Childhood on ScienceDirect(Opens new window)
Hardbound, 1872 Pages
Published: DEC-2008
ISBN 10: 1-4160-3430-7
ISBN 13: 978-1-4160-3430-8
Imprint: SAUNDERS


By
Stuart Orkin, MD, Chairman, Department of Pediatric Oncology, Dana-Farber Cancer Institute; David G. Nathan Professor of Pediatrics, Harvard Medical School; Investigator, Howard Hughes Medical Institute, Boston, MA
David Nathan, MD, President Emeritus, Dana-Farber Cancer Institue, Robert A. Stranahan Distinguished Professor of Pediatrics, Harvard Medical School, Boston, MA
David Ginsburg, MD, Professor of Medicine, Howard Hughs Medical Institute, University of Michigan School of Medicine, Ann Arbor, MI
A. Thomas Look, MD, Division of Pediatrics, Dana Farber Cancer Institute, Boston, MA
David Fisher, MD, PhD, Professor of Pediatrics, Harvard Medical School, Boston, MA
Samuel Lux

Description
To address the exponential growth in the fields of pediatric hematology and oncology, this classic reference has been separated into two distinct volumes. With this volume, devoted strictly to pediatric hematology, and another to pediatric oncology, you’ll keep you on the cutting-edge of these two specialties. The completely revised 7th edition of Nathan and Oski’s Hematology of Infancy and Childhood is now in full color, and provides you with the most comprehensive, authoritative, up-to-date information for diagnosing and treating children with hematologic disorders. It brings together the pathophysiology of disease with detailed clinical guidance on diagnosis and management for the full range of blood diseases that you encounter in everyday practice. Written by the leading names in pediatric hematology, this resource is an essential tool for anyone involved in caring for children with hematologic disorders. And, as an Expert Consult title, this thoroughly updated 7th edition comes with access to the complete contents online, fully searchable.

Audience:
Pediatrics, Hematology/Oncology


 
Last update: 6 Nov 2011